Poll

Poll: Interstitial Lung Disease Risk

09/18/2020

A recent study showed that patients with newly diagnosed systemic autoimmune rheumatic diseases are at a significantly increased risk for interstitial lung disease (ILD). In that study, the incidence rate for ILD was greatest among patients with systemic sclerosis. Based on what you have seen in your practice, patients with which systemic autoimmune rheumatic disease are most likely to develop ILD?

Systemic sclerosis

Dermatomyositis

Polymyositis

Primary Sjögren syndrome

Rheumatoid arthritis

Systemic lupus erythematosus

Other

Popular Articles

News

Mediterranean Diet May Ease Lupus Activity, Cardiovascular Risk

07/09/2021

The researchers analyzed how the Mediterranean diet influences disease activity, damage accrual, and cardiovascular disease risk markers among patients with systemic lupus erythematosus. Here is what they found.

The researchers analyzed how the...

07/09/2021

Autoimmune

Older Patients With Systemic Sclerosis May Need More Frequent Follow-Ups

11/25/2020

In systemic sclerosis, there is controversy around the relationship between the age at disease onset, disease course, and clinical characteristics. Researchers have shed some light on the connections. Here is what they found.

In systemic sclerosis, there is...

11/25/2020

Autoimmune

Podcasts

Dr Misha Rosenbach Discusses the Impact of the Pandemic on Sarcoidosis Treatment

10/07/2020

In this podcast, Misha Rosenbach, MD, discusses how the COVID-19 pandemic has affected patients with sarcoidosis.

In this podcast, Misha...

10/07/2020

Autoimmune

News

Cosmetic Camouflage Boosts Quality of Life in Women With SLE and Facial Skin Damage

08/21/2020

Findings from a recent study showed women with systemic lupus erythematous and permanent facial skin damage experienced improvements in quality of life after using cosmetic camouflage.

Findings from a recent study...

08/21/2020

Autoimmune

Biosimilars: What Providers Need to Know

Conference Coverage

07/12/2020

At IAS 2020, Jonathan Kay, MD, outlined the development, legislation, and economic aspects of biosimilars.

At IAS 2020, Jonathan Kay, MD,...

07/12/2020

Autoimmune

Stay In the Know

Autoimmune Newsletter

Poll: Interstitial Lung Disease Risk

Systemic sclerosis

Dermatomyositis

Polymyositis

Primary Sjögren syndrome

Rheumatoid arthritis

Systemic lupus erythematosus

Other

Popular Articles

Stay In the Know

Specialties

Events

Year Round Education

HMP Global Products